Alzheimer's Disease Clinical Trials

Showing 661-680 of 1,974 trials

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

NCT05476783

This is an open-label long term extension study for participants with Alzheimer's disease (AD) who have completed Protocol TB006AD2102 (lead-in study) or participants who would have been eligible for the lead-in study but were not enrolled (de novo). The study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TB006. The total study duration for each participant will be up to 113 weeks.

Alzheimer's Disease

TrueBinding, Inc.180 participantsStarted Sep 2022

San Diego, California, United States • Delray Beach, Florida, United States • Lady Lake, Florida, United States +10 more locations

TERMINATED

Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial

NCT02781220

The main purpose of this study is to build upon the evidence captured in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS; NCT02420756) trial to include valuable information regarding patient-reported outcomes and physician confidence in diagnosis and management based on the Implications for Management of PET Amyloid Classification Technology (IMPACT; NCT number not yet assigned) trial design.

Mild Cognitive ImpairmentDementiaAlzheimer's Disease

University of Utah69 participantsStarted Jul 2016

Salt Lake City, Utah, United States

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial

Related Searches

Sensory-Evoked Cortical Gamma Oscillation

Prevalence of Alzheimer's Disease Pathology in the Community

Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults

Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease

Determination of Walking, Balance, Fall Risk and Kinesiophobia in Individulas with Alzheimer's Dementation

Role of Gait Analysis in Different Type of Dementia

A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Shared Decision Making About Medication Use for People With Multiple Health Problems

Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

An Objective Assessment Tool for Evaluating Functioning in Older Adults

Promoting Independence With Compensatory Cognitive Rehabilitation

Nut Supplementation to Mitigate Post-stroke Cognitive Decline

Deprescribing Antipsychotics in Long-Term Care

Alzheimer's Disease Neuroimaging Initiative 2